OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $155,051 Invested

2014

Duke University

Carol Colton, PhD

Slowing arginine utilization by inhibiting arginase and ornithine decarboxylase with DFMO

  • Funding Amount: $155,051
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Closed